| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronavirus Infections | 2 | 2020 | 63 | 0.860 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 70 | 0.850 |
Why?
|
| Heart Defects, Congenital | 4 | 2022 | 61 | 0.750 |
Why?
|
| Pulmonary Artery | 4 | 2024 | 37 | 0.670 |
Why?
|
| Histones | 4 | 2017 | 177 | 0.590 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2014 | 1 | 0.520 |
Why?
|
| Septal Occluder Device | 1 | 2014 | 1 | 0.520 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2023 | 147 | 0.510 |
Why?
|
| Health Status Disparities | 1 | 2020 | 583 | 0.500 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 195 | 0.500 |
Why?
|
| Military Medicine | 1 | 2014 | 9 | 0.490 |
Why?
|
| Air Ambulances | 1 | 2014 | 5 | 0.490 |
Why?
|
| DNA Damage | 3 | 2017 | 341 | 0.480 |
Why?
|
| Capsule Endoscopy | 2 | 2014 | 3 | 0.440 |
Why?
|
| Catheterization | 1 | 2010 | 23 | 0.390 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2024 | 13 | 0.370 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2020 | 146 | 0.350 |
Why?
|
| Humans | 34 | 2024 | 34853 | 0.350 |
Why?
|
| Infant | 7 | 2024 | 1014 | 0.320 |
Why?
|
| Ileal Diseases | 1 | 2007 | 2 | 0.320 |
Why?
|
| Jejunal Diseases | 1 | 2007 | 2 | 0.320 |
Why?
|
| Hyperpigmentation | 1 | 2007 | 10 | 0.310 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2006 | 193 | 0.310 |
Why?
|
| Intubation, Intratracheal | 2 | 2020 | 22 | 0.300 |
Why?
|
| Intestinal Mucosa | 1 | 2007 | 115 | 0.290 |
Why?
|
| Military Personnel | 3 | 2016 | 67 | 0.280 |
Why?
|
| Pulmonary Veins | 2 | 2019 | 8 | 0.250 |
Why?
|
| United States | 7 | 2020 | 3894 | 0.250 |
Why?
|
| Home Nursing | 1 | 2003 | 7 | 0.240 |
Why?
|
| Treatment Outcome | 4 | 2024 | 1349 | 0.230 |
Why?
|
| Prostatic Neoplasms | 2 | 2022 | 794 | 0.230 |
Why?
|
| DNA Repair | 1 | 2004 | 181 | 0.230 |
Why?
|
| Alkanesulfonic Acids | 1 | 2022 | 7 | 0.230 |
Why?
|
| Fluorocarbons | 1 | 2022 | 19 | 0.220 |
Why?
|
| Cyclin B | 2 | 1999 | 7 | 0.220 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 21 | 0.210 |
Why?
|
| Male | 16 | 2022 | 18870 | 0.210 |
Why?
|
| Dementia | 1 | 2003 | 133 | 0.210 |
Why?
|
| Health Services Needs and Demand | 1 | 2003 | 143 | 0.210 |
Why?
|
| Fungal Proteins | 3 | 2004 | 130 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2022 | 386 | 0.210 |
Why?
|
| Child | 7 | 2022 | 2875 | 0.200 |
Why?
|
| DNA | 1 | 2004 | 549 | 0.200 |
Why?
|
| Caregivers | 1 | 2003 | 167 | 0.200 |
Why?
|
| Risk Factors | 3 | 2020 | 3414 | 0.200 |
Why?
|
| Heart Ventricles | 2 | 2019 | 121 | 0.190 |
Why?
|
| Neuromuscular Blockade | 1 | 2020 | 1 | 0.190 |
Why?
|
| Female | 16 | 2022 | 19873 | 0.190 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 166 | 0.190 |
Why?
|
| Adipocytes | 1 | 2020 | 54 | 0.190 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 19 | 0.180 |
Why?
|
| Fatty Liver | 1 | 2020 | 56 | 0.180 |
Why?
|
| Rhinitis | 1 | 2019 | 17 | 0.180 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1999 | 3 | 0.180 |
Why?
|
| Sinusitis | 1 | 2019 | 19 | 0.170 |
Why?
|
| Cyclin E | 1 | 1999 | 13 | 0.170 |
Why?
|
| CDC2 Protein Kinase | 1 | 1999 | 17 | 0.170 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1999 | 24 | 0.170 |
Why?
|
| Patient Care Planning | 1 | 2019 | 14 | 0.170 |
Why?
|
| Fontan Procedure | 1 | 2019 | 9 | 0.170 |
Why?
|
| Arteriovenous Fistula | 1 | 2019 | 14 | 0.170 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2018 | 5 | 0.170 |
Why?
|
| Exosomes | 1 | 2020 | 97 | 0.170 |
Why?
|
| Rural Population | 1 | 2020 | 253 | 0.170 |
Why?
|
| Registries | 3 | 2015 | 330 | 0.170 |
Why?
|
| Infant, Newborn | 5 | 2024 | 871 | 0.160 |
Why?
|
| Comorbidity | 1 | 2020 | 606 | 0.160 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2017 | 4 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2023 | 1353 | 0.160 |
Why?
|
| Esophagus | 1 | 2017 | 41 | 0.150 |
Why?
|
| Child, Preschool | 4 | 2015 | 1318 | 0.150 |
Why?
|
| Feasibility Studies | 2 | 2023 | 196 | 0.150 |
Why?
|
| Aspergillus nidulans | 3 | 1996 | 7 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2016 | 16 | 0.150 |
Why?
|
| Skin | 1 | 2017 | 173 | 0.140 |
Why?
|
| Recombination, Genetic | 3 | 2006 | 90 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2003 | 881 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2024 | 1961 | 0.140 |
Why?
|
| Cardiology | 1 | 2015 | 16 | 0.140 |
Why?
|
| Fatigue | 1 | 2016 | 79 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 592 | 0.140 |
Why?
|
| Genes, Fungal | 2 | 1996 | 38 | 0.140 |
Why?
|
| Neurospora crassa | 2 | 1994 | 9 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2004 | 653 | 0.130 |
Why?
|
| Models, Genetic | 2 | 2006 | 149 | 0.130 |
Why?
|
| Foreign-Body Migration | 1 | 2014 | 2 | 0.130 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 10 | 0.130 |
Why?
|
| Prosthesis Design | 1 | 2014 | 26 | 0.130 |
Why?
|
| Device Removal | 1 | 2014 | 9 | 0.130 |
Why?
|
| Genes, Regulator | 1 | 1994 | 25 | 0.130 |
Why?
|
| Prevalence | 2 | 2016 | 1425 | 0.130 |
Why?
|
| Condoms | 1 | 2015 | 132 | 0.130 |
Why?
|
| Conserved Sequence | 1 | 1994 | 106 | 0.120 |
Why?
|
| Gastrointestinal Transit | 1 | 2014 | 2 | 0.120 |
Why?
|
| Adolescent | 5 | 2022 | 5035 | 0.120 |
Why?
|
| Monitoring, Ambulatory | 1 | 2014 | 13 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2004 | 550 | 0.120 |
Why?
|
| Gastric Emptying | 1 | 2014 | 14 | 0.120 |
Why?
|
| Nitrogen | 1 | 1994 | 63 | 0.120 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2015 | 165 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 2014 | 63 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2006 | 878 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2022 | 206 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 2128 | 0.110 |
Why?
|
| Time Factors | 2 | 2014 | 1681 | 0.110 |
Why?
|
| Silicones | 1 | 2012 | 7 | 0.110 |
Why?
|
| Pneumothorax | 1 | 2012 | 9 | 0.110 |
Why?
|
| Ethanol | 1 | 1994 | 188 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2012 | 9 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2012 | 18 | 0.110 |
Why?
|
| Sexual Partners | 1 | 2015 | 308 | 0.110 |
Why?
|
| Fibrosis | 2 | 2023 | 146 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2022 | 1149 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 1994 | 522 | 0.100 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 1490 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2015 | 587 | 0.090 |
Why?
|
| Mutation | 4 | 2006 | 1023 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 781 | 0.090 |
Why?
|
| Karyopherins | 2 | 1999 | 6 | 0.090 |
Why?
|
| Cell Movement | 2 | 2022 | 545 | 0.080 |
Why?
|
| Middle Aged | 6 | 2016 | 9642 | 0.080 |
Why?
|
| Young Adult | 2 | 2014 | 4012 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2007 | 8 | 0.080 |
Why?
|
| Vitamin K 3 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Biopsy | 1 | 2007 | 151 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 211 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2007 | 31 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2006 | 1124 | 0.070 |
Why?
|
| Animals | 7 | 2020 | 14307 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 1999 | 287 | 0.070 |
Why?
|
| Serine | 1 | 2006 | 72 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 206 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2006 | 116 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2007 | 77 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2007 | 105 | 0.070 |
Why?
|
| Metallothionein | 1 | 2004 | 21 | 0.060 |
Why?
|
| Teratogens | 1 | 2004 | 12 | 0.060 |
Why?
|
| Acetylation | 1 | 2004 | 94 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 5 | 0.060 |
Why?
|
| Reproduction | 1 | 2004 | 63 | 0.060 |
Why?
|
| Transfection | 2 | 2020 | 496 | 0.060 |
Why?
|
| Lung | 1 | 2007 | 413 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2020 | 1802 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 112 | 0.060 |
Why?
|
| Stents | 1 | 2024 | 59 | 0.060 |
Why?
|
| Health Care Sector | 1 | 2003 | 6 | 0.060 |
Why?
|
| Palliative Care | 1 | 2024 | 52 | 0.060 |
Why?
|
| Models, Organizational | 1 | 2003 | 33 | 0.060 |
Why?
|
| Homeostasis | 1 | 2004 | 172 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1999 | 286 | 0.060 |
Why?
|
| Chromatin | 1 | 2004 | 164 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 51 | 0.060 |
Why?
|
| Unfolded Protein Response | 1 | 2022 | 17 | 0.060 |
Why?
|
| Cadmium | 1 | 2023 | 56 | 0.060 |
Why?
|
| Aged | 3 | 2016 | 6448 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 1996 | 226 | 0.060 |
Why?
|
| Peer Review | 1 | 2002 | 2 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2022 | 5 | 0.050 |
Why?
|
| Collateral Circulation | 1 | 2022 | 10 | 0.050 |
Why?
|
| Endocrine System | 1 | 2002 | 12 | 0.050 |
Why?
|
| Cyclin B1 | 2 | 1999 | 16 | 0.050 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2004 | 72 | 0.050 |
Why?
|
| Xenopus | 2 | 1999 | 44 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2022 | 46 | 0.050 |
Why?
|
| Adult | 5 | 2019 | 11034 | 0.050 |
Why?
|
| Biological Transport | 2 | 1999 | 175 | 0.050 |
Why?
|
| Androgens | 1 | 2002 | 87 | 0.050 |
Why?
|
| Models, Biological | 1 | 2004 | 642 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 245 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2004 | 287 | 0.050 |
Why?
|
| Leptin | 1 | 2022 | 115 | 0.050 |
Why?
|
| Metabolism | 1 | 2020 | 9 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2006 | 874 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 49 | 0.050 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2020 | 2 | 0.050 |
Why?
|
| Estrogens | 1 | 2002 | 190 | 0.050 |
Why?
|
| Glycolysis | 1 | 2020 | 66 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2023 | 283 | 0.050 |
Why?
|
| Muscle Relaxation | 1 | 2020 | 17 | 0.050 |
Why?
|
| Binding Sites | 2 | 1999 | 597 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 1996 | 249 | 0.050 |
Why?
|
| Aerosols | 1 | 2020 | 48 | 0.050 |
Why?
|
| Equipment Design | 1 | 2020 | 127 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2002 | 207 | 0.050 |
Why?
|
| Mice | 3 | 2020 | 5668 | 0.050 |
Why?
|
| Nasal Lavage | 1 | 2019 | 1 | 0.040 |
Why?
|
| Endoscopy | 1 | 2019 | 15 | 0.040 |
Why?
|
| Azygos Vein | 1 | 2019 | 1 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 1999 | 21 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 43 | 0.040 |
Why?
|
| Hydro-Lyases | 2 | 1996 | 8 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2019 | 44 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 68 | 0.040 |
Why?
|
| Transferases | 2 | 1996 | 12 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1999 | 30 | 0.040 |
Why?
|
| Autophagy | 1 | 2020 | 111 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1998 | 58 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 49 | 0.040 |
Why?
|
| Phthalazines | 1 | 2017 | 4 | 0.040 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2017 | 4 | 0.040 |
Why?
|
| Lyases | 2 | 1996 | 51 | 0.040 |
Why?
|
| Echocardiography | 1 | 2018 | 144 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 142 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1998 | 184 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 1426 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 608 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 1999 | 351 | 0.040 |
Why?
|
| Piperazines | 1 | 2017 | 109 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2017 | 323 | 0.040 |
Why?
|
| Weight Loss | 1 | 2017 | 124 | 0.040 |
Why?
|
| Ships | 1 | 2016 | 7 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1996 | 11 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1996 | 30 | 0.030 |
Why?
|
| Peptides | 1 | 1999 | 308 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 859 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 355 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 469 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1996 | 63 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 468 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1994 | 31 | 0.030 |
Why?
|
| Glutamine | 1 | 1994 | 31 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 288 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 965 | 0.030 |
Why?
|
| Erythromycin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Phosphorus-Oxygen Lyases | 1 | 1993 | 5 | 0.030 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 1993 | 14 | 0.030 |
Why?
|
| Pressure | 1 | 2014 | 36 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1994 | 257 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 2014 | 52 | 0.030 |
Why?
|
| Body Temperature | 1 | 2014 | 39 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 51 | 0.030 |
Why?
|
| Stomach | 1 | 2014 | 43 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 336 | 0.030 |
Why?
|
| Morphine | 1 | 2014 | 80 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1530 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1993 | 167 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 342 | 0.030 |
Why?
|
| Goiter, Nodular | 1 | 2012 | 2 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2012 | 6 | 0.030 |
Why?
|
| Bradycardia | 1 | 2012 | 6 | 0.030 |
Why?
|
| Patient Selection | 1 | 2013 | 154 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2015 | 435 | 0.030 |
Why?
|
| Body Weight | 1 | 2013 | 404 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 790 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 19 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2561 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 79 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 81 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 480 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 605 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 391 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 707 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 964 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 18 | 0.020 |
Why?
|
| Infertility | 1 | 2004 | 17 | 0.020 |
Why?
|
| Rats | 2 | 2004 | 3261 | 0.020 |
Why?
|
| Copper | 1 | 2004 | 101 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 2004 | 67 | 0.010 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2002 | 17 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 484 | 0.010 |
Why?
|
| Benzhydryl Compounds | 1 | 2002 | 42 | 0.010 |
Why?
|
| Phenols | 1 | 2002 | 76 | 0.010 |
Why?
|
| Research Design | 1 | 2002 | 292 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 1503 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 984 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 901 | 0.010 |
Why?
|
| ran GTP-Binding Protein | 1 | 1998 | 3 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 1998 | 11 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1998 | 73 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1998 | 34 | 0.010 |
Why?
|
| Public Health | 1 | 2002 | 348 | 0.010 |
Why?
|
| Hela Cells | 1 | 1998 | 344 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 1300 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1996 | 56 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1996 | 60 | 0.010 |
Why?
|
| Introns | 1 | 1996 | 67 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 161 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 196 | 0.010 |
Why?
|
| 3-Phosphoshikimate 1-Carboxyvinyltransferase | 1 | 1993 | 1 | 0.010 |
Why?
|
| Quinic Acid | 1 | 1993 | 2 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1996 | 467 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1996 | 436 | 0.010 |
Why?
|